Explore our collection of Echosens white papers, featuring expert insights and scientific evidence on liver health, non-invasive assessment, and the use of FibroScan® in clinical practice.
In this white paper, pediatric hepatologist Dr. Alisha Mavis explores how recognizing pediatric MASLD earlier and integrating FibroScan® into clinical care can help providers assess risk, monitor disease progression, and support more informed, long-term care.
Discover how non-invasive liver assessment can help clinicians and families better understand liver health and take action earlier.
This white paper explores why VCTE® has become a global reference in transient elastography, from measurement reliability and standardization to its advantages over other elastography techniques.
Discover the technology backed by 6,000+ peer-reviewed publications and understand what makes VCTE® a trusted standard in clinical practice.
This white paper explores how Guided VCTE® brings greater simplicity and efficiency to liver assessment, with an intuitive scanning experience designed to streamline the exam process.
Discover the technology, its key benefits, and how it can support a more seamless FibroScan® experience.
This white paper explores how non-invasive liver assessment with FibroScan® can help accelerate patient enrollment, reduce screen failure rates, and monitor therapeutic response throughout clinical trials.
Discover how Echosens solutions can help optimize trial execution and support the development of new MASH therapies.